ES2351357T3 - Bencimidazoles útiles como inhibidores de proteínas cinasas. - Google Patents
Bencimidazoles útiles como inhibidores de proteínas cinasas. Download PDFInfo
- Publication number
- ES2351357T3 ES2351357T3 ES06787944T ES06787944T ES2351357T3 ES 2351357 T3 ES2351357 T3 ES 2351357T3 ES 06787944 T ES06787944 T ES 06787944T ES 06787944 T ES06787944 T ES 06787944T ES 2351357 T3 ES2351357 T3 ES 2351357T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- image
- independently
- formula
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70239905P | 2005-07-26 | 2005-07-26 | |
| US702399P | 2005-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2351357T3 true ES2351357T3 (es) | 2011-02-03 |
Family
ID=37680602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES06787944T Expired - Lifetime ES2351357T3 (es) | 2005-07-26 | 2006-07-21 | Bencimidazoles útiles como inhibidores de proteínas cinasas. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8076343B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1937667B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5255438B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080034483A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101291927A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE484501T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006276088A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2616159A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602006017574D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2351357T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL188942A0 (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080967L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ566021A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2415853C2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200745088A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007015923A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200800992B (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7989465B2 (en) | 2007-10-19 | 2011-08-02 | Avila Therapeutics, Inc. | 4,6-disubstituted pyrimidines useful as kinase inhibitors |
| JP5600063B2 (ja) | 2007-10-19 | 2014-10-01 | セルジーン アビロミクス リサーチ, インコーポレイテッド | ヘテロアリール化合物およびその使用 |
| US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
| JP2011523646A (ja) | 2008-05-21 | 2011-08-18 | アリアド・ファーマシューティカルズ・インコーポレイテッド | キナーゼ阻害剤としてのリン誘導体 |
| AU2012250517B2 (en) | 2011-05-04 | 2016-05-19 | Takeda Pharmaceutical Company Limited | Compounds for inhibiting cell proliferation in EGFR-driven cancers |
| JP6469567B2 (ja) | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
| US9336046B2 (en) | 2012-06-15 | 2016-05-10 | International Business Machines Corporation | Transaction abort processing |
| US9512136B2 (en) * | 2012-11-26 | 2016-12-06 | Universal Display Corporation | Organic electroluminescent materials and devices |
| EP2976336A1 (en) * | 2013-03-21 | 2016-01-27 | Bayer Pharma Aktiengesellschaft | 3-heteroaryl substituted indazoles |
| US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
| WO2014170421A1 (en) * | 2013-04-19 | 2014-10-23 | F. Hoffmann-La Roche Ag | Serine/threonine kinase inhibitors |
| ITUA20164278A1 (it) * | 2016-06-10 | 2017-12-10 | International Soc For Drug Development S R L | COMPOSTI 2-OXO-1,2-DIIDROPIRIDIN-3-CARBOSSAMMIDE E LORO USO COME INIBITORI DUALI DI PDK1/AurA |
| AU2018352695A1 (en) | 2017-10-19 | 2020-05-28 | Effector Therapeutics, Inc. | Benzimidazole-indole inhibitors of Mnk1 and Mnk2 |
| CN112552287B (zh) * | 2020-12-16 | 2021-11-30 | 北京华氏精恒医药科技有限公司 | 一种吲哚类衍生物药物制剂及其制备方法 |
| CN118055931A (zh) * | 2021-12-23 | 2024-05-17 | 杭州多域生物技术有限公司 | 一种五元并六元化合物、制备方法、药物组合物和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE305465T1 (de) | 1998-11-17 | 2005-10-15 | Kumiai Chemical Industry Co | Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und agrikulte/hortikulte fungizide |
| JP4535350B2 (ja) * | 1998-11-17 | 2010-09-01 | クミアイ化学工業株式会社 | ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤 |
| MXPA02003436A (es) * | 1999-10-07 | 2002-08-20 | Amgen Inc | Inhibidores de triazina cinasa. |
| KR20030024659A (ko) | 2000-02-17 | 2003-03-26 | 암겐 인코포레이티드 | 키나제 억제제 |
| KR100833371B1 (ko) * | 2001-04-27 | 2008-05-28 | 젠야쿠코교가부시키가이샤 | 헤테로시클릭 화합물 및 이를 유효 성분으로 하는 항종양제 |
| FR2833948B1 (fr) * | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
| ATE457025T1 (de) * | 2002-05-23 | 2010-02-15 | Cytopia Res Pty Ltd | Kinaseinhibitoren |
| AR042052A1 (es) * | 2002-11-15 | 2005-06-08 | Vertex Pharma | Diaminotriazoles utiles como inhibidores de proteinquinasas |
| UA80767C2 (en) * | 2002-12-20 | 2007-10-25 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| ES2389203T3 (es) * | 2004-01-12 | 2012-10-24 | Ym Biosciences Australia Pty Ltd | Inhibidores de quinasa selectivos |
-
2006
- 2006-07-21 RU RU2008106949/04A patent/RU2415853C2/ru not_active IP Right Cessation
- 2006-07-21 US US11/492,643 patent/US8076343B2/en not_active Expired - Fee Related
- 2006-07-21 NZ NZ566021A patent/NZ566021A/en not_active IP Right Cessation
- 2006-07-21 EP EP06787944A patent/EP1937667B1/en not_active Expired - Lifetime
- 2006-07-21 WO PCT/US2006/028149 patent/WO2007015923A2/en not_active Ceased
- 2006-07-21 KR KR1020087004634A patent/KR20080034483A/ko not_active Ceased
- 2006-07-21 AU AU2006276088A patent/AU2006276088A1/en not_active Abandoned
- 2006-07-21 DE DE602006017574T patent/DE602006017574D1/de not_active Expired - Lifetime
- 2006-07-21 AT AT06787944T patent/ATE484501T1/de not_active IP Right Cessation
- 2006-07-21 ES ES06787944T patent/ES2351357T3/es not_active Expired - Lifetime
- 2006-07-21 CN CNA2006800343024A patent/CN101291927A/zh active Pending
- 2006-07-21 ZA ZA200800992A patent/ZA200800992B/xx unknown
- 2006-07-21 EP EP10185388.5A patent/EP2336122B1/en not_active Expired - Lifetime
- 2006-07-21 JP JP2008523972A patent/JP5255438B2/ja not_active Expired - Fee Related
- 2006-07-21 CA CA002616159A patent/CA2616159A1/en not_active Abandoned
- 2006-07-26 TW TW095127328A patent/TW200745088A/zh unknown
-
2008
- 2008-01-22 IL IL188942A patent/IL188942A0/en unknown
- 2008-02-26 NO NO20080967A patent/NO20080967L/no not_active Application Discontinuation
-
2013
- 2013-02-13 JP JP2013025417A patent/JP2013082757A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006276088A1 (en) | 2007-02-08 |
| EP1937667A2 (en) | 2008-07-02 |
| RU2415853C2 (ru) | 2011-04-10 |
| TW200745088A (en) | 2007-12-16 |
| US8076343B2 (en) | 2011-12-13 |
| JP5255438B2 (ja) | 2013-08-07 |
| US20070099920A1 (en) | 2007-05-03 |
| CN101291927A (zh) | 2008-10-22 |
| ATE484501T1 (de) | 2010-10-15 |
| JP2009502921A (ja) | 2009-01-29 |
| ZA200800992B (en) | 2009-09-30 |
| JP2013082757A (ja) | 2013-05-09 |
| EP2336122A1 (en) | 2011-06-22 |
| DE602006017574D1 (de) | 2010-11-25 |
| NO20080967L (no) | 2008-04-22 |
| WO2007015923A3 (en) | 2007-04-19 |
| KR20080034483A (ko) | 2008-04-21 |
| WO2007015923A2 (en) | 2007-02-08 |
| EP2336122B1 (en) | 2014-05-14 |
| CA2616159A1 (en) | 2007-02-08 |
| EP1937667B1 (en) | 2010-10-13 |
| IL188942A0 (en) | 2008-04-13 |
| WO2007015923A8 (en) | 2008-04-03 |
| RU2008106949A (ru) | 2009-09-10 |
| NZ566021A (en) | 2011-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2006315334B2 (en) | Aminopyrimidines useful as kinase inhibitors | |
| JP7425724B2 (ja) | Ehmt2阻害剤としてのアミン置換複素環化合物及びその誘導体 | |
| JP5572087B2 (ja) | キナーゼ阻害として有用なアミノピリミジン | |
| BRPI0610184A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de cáncer e para a produção de um efeito anti-proliferativo em um animal de sanque quente, e, composição farmacêutica | |
| JP2013082757A (ja) | プロテインキナーゼ阻害薬として有用なベンズイミダゾール | |
| RS61759B1 (sr) | Jedinjenja 1-cijano-pirolidina kao inhibitori usp30 | |
| BRPI0712816B1 (pt) | compostos de pirrolpirimidina e seu uso | |
| CN101687852A (zh) | 可用作激酶抑制剂的噻唑类和吡唑类化合物 | |
| WO2007095124A2 (en) | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors | |
| CN101801959A (zh) | 可用作激酶抑制剂的氨基嘧啶类化合物 | |
| AU2006279376B2 (en) | Pyrazine kinase inhibitors | |
| JP2025535036A (ja) | Parg阻害化合物 | |
| ES2355756T3 (es) | Derivados de pirimidona bicíclicos sustituidos. | |
| CN104844566A (zh) | 一种新型结构的激酶抑制剂 | |
| BR112021013429A2 (pt) | Composto, composição farmacêutica, e, uso do composto | |
| EP3589615B1 (en) | Pyridyl derivatives as bromodomain inhibitors | |
| MX2008001172A (en) | Benzimidazoles useful as inhibitors of protein kinases | |
| HK1122558A (en) | Benzimidazoles useful as inhibitors of protein kinases | |
| HK1138587A (en) | Thiazoles and pyrazoles useful as kinase inhibitors | |
| HK1142883A (en) | Aminopyrimidines useful as kinase inhibitors | |
| HK1139665A (en) | Aminopyrimidines useful as kinase inhibitors |